Comparison

Desloratadine European Partner

Item no. HY-B0539-10mM
Manufacturer MedChem Express
CASRN 100643-71-8
Amount 10mM/1mL
Quantity options 100 mg 10mM/1mL 1 g 250 mg 25 mg 500 mg 50 mg
Category
Type Inhibitors
Clone N/A
Specific against other
Purity 99.98
Formula C19H19ClN2
Citations [1]Geha, R.S. and E.O. Meltzer, Desloratadine: A new, nonsedating, oral antihistamine. J Allergy Clin Immunol, 2001. 107(4): p. 751-62.
[2]Schroeder, J.T., et al., Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy, 2001. 31(9): p. 1369-77.
[3]Anthes, J.C., et al., Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. Eur J Pharmacol, 2002. 449(3): p. 229-37.
[4]McClellan K, et al. Desloratadine. Drugs. 2001;61(6):789-797.
[5]Agrawal, et al. "Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug." Expert opinion on investigational drugs 10.3 (2001): 547-560.
[6]Kowalski, et al. "Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine." Allergy 60.1 (2005): 80-85.
Smiles ClC1=CC=C2C(CCC3=CC=CN=C3/C2=C4CCNCC/4)=C1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Sch34117
Shipping Condition Room temperature
Available
Manufacturer - Type
Natural Products
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Histamine Receptor; Leukotriene Receptor; TNF Receptor
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
310.828
Product Description
Desloratadine (Sch34117) is an orally active and selective H1 receptor antagonist (Ki=0.9 nM) with anti-inflammatory and anti-allergic activities. Desloratadine inhibits the release of histamine and LTC4 from human basophils and targets the regulatory signals of IL-4 and IL-13 production in basophils. Desloratadine significantly alleviates SAR symptoms in patients with concurrent asthma and can be used in the study of seasonal allergic rhinitis and chronic idiopathic urticaria[1][2][3][4][5][6].
Manufacturer - Research Area
Inflammation/Immunology
Solubility
DMSO : 6.67 mg/mL (ultrasonic; warming; heat to 60°C)|H2O : < 0.1 mg/mL
Manufacturer - Pathway
Apoptosis; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling
Isoform
H1 Receptor; Human Endogenous Metabolite
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close